Communications Biology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：骨发育;蛋白酶;软骨内成骨 经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Editor Review Started 3rd Jul 24 Initial Manuscript Review Started 21st Jun 24 Editor Assigned 19th Jun 24 Submission 14th Jun 24 Manuscript Transferred 14th Jun 24 已经过去快一个月啦 7号收到的送审邮件 更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。 Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received Review #</a>1 received Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed Reviewer #</a>1 agreed 5 reviewer(s) invited Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜 经验分享：第一次尝试。 更新攒人品拉！ Initial Manuscript Review Started 26th Mar 24 Editor Assigned 25th Mar 24 Submission 20th Mar 24 希望可以顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学 经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]

2024-06-12 xyzt 来自广东省

投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。

31 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：骨发育;蛋白酶;软骨内成骨 经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Editor Review Started 3rd Jul 24 Initial Manuscript Review Started 21st Jun 24 Editor Assigned 19th Jun 24 Submission 14th Jun 24 Manuscript Transferred 14th Jun 24 已经过去快一个月啦 7号收到的送审邮件 更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。 Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received Review #</a>1 received Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed Reviewer #</a>1 agreed 5 reviewer(s) invited Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜 经验分享：第一次尝试。 更新攒人品拉！ Initial Manuscript Review Started 26th Mar 24 Editor Assigned 25th Mar 24 Submission 20th Mar 24 希望可以顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学 经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]

2024-07-24 ms8000000795739494 来自江苏省

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：骨发育;蛋白酶;软骨内成骨
经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：骨发育;蛋白酶;软骨内成骨 经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Editor Review Started 3rd Jul 24 Initial Manuscript Review Started 21st Jun 24 Editor Assigned 19th Jun 24 Submission 14th Jun 24 Manuscript Transferred 14th Jun 24 已经过去快一个月啦 7号收到的送审邮件 更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。 Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received Review #</a>1 received Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed Reviewer #</a>1 agreed 5 reviewer(s) invited Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜 经验分享：第一次尝试。 更新攒人品拉！ Initial Manuscript Review Started 26th Mar 24 Editor Assigned 25th Mar 24 Submission 20th Mar 24 希望可以顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学 经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]

2024-07-10 ms2000000117316111 来自广西

审稿速度:6.0 | 投稿命中率:50.0
经验分享：Editor Review Started 3rd Jul 24
Initial Manuscript Review Started 21st Jun 24
Editor Assigned 19th Jun 24
Submission 14th Jun 24
Manuscript Transferred 14th Jun 24

已经过去快一个月啦
7号收到的送审邮件
更新攒人品

29 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：骨发育;蛋白酶;软骨内成骨 经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Editor Review Started 3rd Jul 24 Initial Manuscript Review Started 21st Jun 24 Editor Assigned 19th Jun 24 Submission 14th Jun 24 Manuscript Transferred 14th Jun 24 已经过去快一个月啦 7号收到的送审邮件 更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。 Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received Review #</a>1 received Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed Reviewer #</a>1 agreed 5 reviewer(s) invited Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜 经验分享：第一次尝试。 更新攒人品拉！ Initial Manuscript Review Started 26th Mar 24 Editor Assigned 25th Mar 24 Submission 20th Mar 24 希望可以顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学 经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]

2024-06-20 ms2000000208112241 来自辽宁省

6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。

31 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：骨发育;蛋白酶;软骨内成骨 经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Editor Review Started 3rd Jul 24 Initial Manuscript Review Started 21st Jun 24 Editor Assigned 19th Jun 24 Submission 14th Jun 24 Manuscript Transferred 14th Jun 24 已经过去快一个月啦 7号收到的送审邮件 更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。 Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received Review #</a>1 received Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed Reviewer #</a>1 agreed 5 reviewer(s) invited Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜 经验分享：第一次尝试。 更新攒人品拉！ Initial Manuscript Review Started 26th Mar 24 Editor Assigned 25th Mar 24 Submission 20th Mar 24 希望可以顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学 经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]

2024-05-11 流离岁月来自浙江省

请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。
Review #2 received
Review #1 received
Reviewer #2 agreed
Reviewer #1 agreed
5 reviewer(s) invited
Invitations sent on 13 Mar, 2024

90 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：骨发育;蛋白酶;软骨内成骨 经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Editor Review Started 3rd Jul 24 Initial Manuscript Review Started 21st Jun 24 Editor Assigned 19th Jun 24 Submission 14th Jun 24 Manuscript Transferred 14th Jun 24 已经过去快一个月啦 7号收到的送审邮件 更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。 Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received Review #</a>1 received Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed Reviewer #</a>1 agreed 5 reviewer(s) invited Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜 经验分享：第一次尝试。 更新攒人品拉！ Initial Manuscript Review Started 26th Mar 24 Editor Assigned 25th Mar 24 Submission 20th Mar 24 希望可以顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学 经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]

2023-12-14 ms3000001957865221 来自湖北省

decision made好几天了都没有更新状态，是被拒了吗

58 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：骨发育;蛋白酶;软骨内成骨 经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Editor Review Started 3rd Jul 24 Initial Manuscript Review Started 21st Jun 24 Editor Assigned 19th Jun 24 Submission 14th Jun 24 Manuscript Transferred 14th Jun 24 已经过去快一个月啦 7号收到的送审邮件 更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。 Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received Review #</a>1 received Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed Reviewer #</a>1 agreed 5 reviewer(s) invited Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜 经验分享：第一次尝试。 更新攒人品拉！ Initial Manuscript Review Started 26th Mar 24 Editor Assigned 25th Mar 24 Submission 20th Mar 24 希望可以顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学 经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]

2024-03-26 ms7000000088062990 来自北京

偏重的研究方向：眼科;角膜
经验分享：第一次尝试。
更新攒人品拉！
Initial Manuscript Review Started 26th Mar 24
Editor Assigned 25th Mar 24
Submission 20th Mar 24
希望可以顺利

41 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：骨发育;蛋白酶;软骨内成骨 经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Editor Review Started 3rd Jul 24 Initial Manuscript Review Started 21st Jun 24 Editor Assigned 19th Jun 24 Submission 14th Jun 24 Manuscript Transferred 14th Jun 24 已经过去快一个月啦 7号收到的送审邮件 更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。 Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received Review #</a>1 received Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed Reviewer #</a>1 agreed 5 reviewer(s) invited Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜 经验分享：第一次尝试。 更新攒人品拉！ Initial Manuscript Review Started 26th Mar 24 Editor Assigned 25th Mar 24 Submission 20th Mar 24 希望可以顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学 经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]

2024-02-07 sunyong_97 来自江苏省

Editor Review Started已经两天了，External Editor还是Not Assigned。

49 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：骨发育;蛋白酶;软骨内成骨 经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Editor Review Started 3rd Jul 24 Initial Manuscript Review Started 21st Jun 24 Editor Assigned 19th Jun 24 Submission 14th Jun 24 Manuscript Transferred 14th Jun 24 已经过去快一个月啦 7号收到的送审邮件 更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。 Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received Review #</a>1 received Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed Reviewer #</a>1 agreed 5 reviewer(s) invited Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜 经验分享：第一次尝试。 更新攒人品拉！ Initial Manuscript Review Started 26th Mar 24 Editor Assigned 25th Mar 24 Submission 20th Mar 24 希望可以顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学 经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]

2024-06-03 ms7000000214967727 来自福建省

偏重的研究方向：基因组学
经验分享：6月1日提交，submission状态，希望好运！！！

33 0

[GetPortalCommentsPageByObjectIdResponse(id=2209514, encodeId=4de22209514ac, content=投稿一个多月后收到审稿意见，4个审稿人，共计三十几条意见，给了六个月的时间来返修。虽然影响因子有点低，但审稿严格，难度还是蛮大的，总感觉性价比不太高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=xyzt, createdTime=Wed Jun 12 16:11:14 CST 2024, time=2024-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216628, encodeId=6809221662829, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：骨发育;蛋白酶;软骨内成骨 经验分享：初审三个月，现在已经返修，之前评论的状态更新没发出来，更新一下攒人品，2024-7-24：二审under review开始。等待后续更新。接好运！接接接接接接！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89515745221, createdName=ms8000000795739494, createdTime=Wed Jul 24 14:33:01 CST 2024, time=2024-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214166, encodeId=b985221416654, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Editor Review Started 3rd Jul 24 Initial Manuscript Review Started 21st Jun 24 Editor Assigned 19th Jun 24 Submission 14th Jun 24 Manuscript Transferred 14th Jun 24 已经过去快一个月啦 7号收到的送审邮件 更新攒人品, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ae69093052, createdName=ms2000000117316111, createdTime=Wed Jul 10 00:16:11 CST 2024, time=2024-07-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2210908, encodeId=881f2210908a3, content=6.8 submission 感觉这个刊今年初审都好慢，大家这个月都是多久开始初审的，等的好着急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4549307210, createdName=ms2000000208112241, createdTime=Thu Jun 20 23:29:49 CST 2024, time=2024-06-20, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2204152, encodeId=93da2204152fb, content=请问大家一般是几个审稿人呀？一定要3个审稿人的意见编辑才会做决定吗？我在research square上看到3月份邀请了5个审稿人，2个同意并审完了（1个3月底，1个4月初）但是现在5月份了状态还在under review，这里也没有显示review3 agree的信息。 Review <a href='/topic/show?id=1efd114362fc' target=_blank style='color:#2F92EE;'>#2 received Review #</a>1 received Reviewer <a href='/topic/show?id=24c6114363d5' target=_blank style='color:#2F92EE;'>#2 agreed Reviewer #</a>1 agreed 5 reviewer(s) invited Invitations sent on 13 Mar, 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=114362, encryptionId=1efd114362fc, topicName=2 received Review ), TopicDto(id=114363, encryptionId=24c6114363d5, topicName=2 agreed Reviewer )], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86182534474, createdName=流离岁月, createdTime=Sat May 11 21:50:44 CST 2024, time=2024-05-11, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2174953, encodeId=a76121e495306, content=decision made好几天了都没有更新状态，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abcd9105499, createdName=ms3000001957865221, createdTime=Thu Dec 14 17:04:07 CST 2023, time=2023-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2195546, encodeId=7d7c219554630, content=偏重的研究方向：眼科;角膜 经验分享：第一次尝试。 更新攒人品拉！ Initial Manuscript Review Started 26th Mar 24 Editor Assigned 25th Mar 24 Submission 20th Mar 24 希望可以顺利 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f75577556, createdName=ms7000000088062990, createdTime=Tue Mar 26 22:21:39 CST 2024, time=2024-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2186337, encodeId=8539218633ef8, content=Editor Review Started已经两天了，External Editor还是Not Assigned。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d64b1467806, createdName=sunyong_97, createdTime=Wed Feb 07 12:08:38 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2208056, encodeId=63c12208056d4, content=偏重的研究方向：基因组学 经验分享：6月1日提交，submission状态，希望好运！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab498294868, createdName=ms7000000214967727, createdTime=Mon Jun 03 14:14:56 CST 2024, time=2024-06-03, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2185092, encodeId=3def2185092bd, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤生物学 经验分享：经验分享，第一轮 Stage Start Date Revision Received 31st Jan 24 Waiting for Revision 31st Jan 24 Decision Made 30th Jan 24 Editor Review Started 13th Jan 24 Initial Manuscript Review Started 8th Jan 24 Editor Assigned 8th Jan 24 Submission 28th Dec 23, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608d6458298, createdName=ms1000000620292943, createdTime=Wed Jan 31 20:14:45 CST 2024, time=2024-01-31, status=1, ipAttribution=福建省)]

2024-01-31 ms1000000620292943 来自福建省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤生物学
经验分享：经验分享，第一轮
Stage Start Date
Revision Received 31st Jan 24
Waiting for Revision 31st Jan 24
Decision Made 30th Jan 24
Editor Review Started 13th Jan 24
Initial Manuscript Review Started 8th Jan 24
Editor Assigned 8th Jan 24
Submission 28th Dec 23

49 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务